Using stable isotope dilution, we determined the bioavailability of soilborne lead (Pb) in human adult volunteers. Soil from a residential yard at a mining-impacted federal Superfund site that had negligible amounts of other priority pollutants was dried and screened through a 25-pm mesh sieve. The <250-pm fraction, which likely represents that ingested via hand-to-mouth activity, was then sterilized by exposure to radiation. Ten replicate samples yielded a mean (SD) soil Pb concentration of 2924±36 ppm, and a mean 206Pb/207Pb ratio of 1.1083±0.0002, indicating remarkable soil homogeneity. Six adults with 206Pb/207Pb ratios of > 1.190 were admitted to the clinical research center and fasted overnight prior to dosing with 250 pg Pb/70 kg bw (i.e., 85.5 mg soilf70 kg) in a gelatin capsule. Blood for Pb and 206Pb/207Pb ratios was obtained at 14 time points through 30 hr. Results of the isotopic analyses from these subjects indicate that on average 26.2% ±8.1 of the administered dose was absorbed. Six additional subjects were subsequently studied but ingested soil immediately after a standardized breakfast. Bioavailability in this group was only 2.52% ± 1.7. Collectively, this study provides the first experimental estimates of soil Pb absorption in humans, and should allow for more precise estimates of health risks due to Pb-contaminated soil.
The regulation of environmental contaminants such as lead (Pb) should reflect the potential impact on human health and the environment. With respect to soilborne Pb contamination, the bioavailability of Pb in that medium will to a great extent determine its capacity to adversely affect human health. The U.S. Environmental Protection Agency (U.S. EPA) employs the integrated exposure uptake biokinetic (IEUBK) model for lead to assess environmental Pb hazards in children (1) and has developed an interim simplified biokinetic model for use in adults (2) while the U.S. EPA explores expansion of the IEUBK model to accommodate all age groups. In addition, there are a number of biokinetic models available (3) (4) (5) that are intended for use in adults. The output of these models is affected by a host of exposure and kinetic factors, with the bioavailability of Pb in soil among the more prominent (6) . Unfortunately, this parameter is among the most poorly understood and likely contains a high degree of uncertainty.
In the past, investigators have employed animal models to study the bioavailability of Pb in soil (7, 8) . These studies, however, have primarily focused on predicting bioavailability in children rather than in adults. For example, using immature swine as a surrogate for young children, Casteel et al. (7) conducted a bioavailability study of soils from the Smuggler Mountain Superfund site in Aspen, Colorado. Two soils were tested at three different doses and were administered in daily feed material for 15 days. The average absolute bioavailability in all six test groups was 28%. Employing a rat model, Freeman et al. (8) studied the bioavailability of Pb-contaminated mining waste from the Butte, Montana, Superfund site. Soils with high (3908 ppm) and low (810 ppm) Pb concentrations were mixed with varying amounts of feed material to mimic the soil ingestion pattern of children with pica. Relative bioavailability was measured against a Pb acetate standard that was added as a solution to the feed material. The dietary feeding study was conducted over 39 days. Analysis of blood Pb (PbB) data yielded a relative bioavailability of 20%.
Until now, however, there have been no controlled studies assessing the bioavailability of soilborne Pb in humans. Past human dietary studies employing solubilized Pb in an aqueous vehicle (9) (10) (11) may provide some insight regarding the extent of Pb absorption from soil. However, the Pb/soil matrix is believed to influence absorption through factors such as Pb speciation, particle size distribution, and organic/mineral content of the soil (12) . Steele et al. (12) and Mushak (13) have reviewed the influence of soil characteristics on Pb absorption using epidemiologic studies, in vitro tests, and animal bioassays. For example, particle size affects both the dissolution of Pb in in vitro systems (14) and the bioavailability of Pb in animal models (15) . The dissolution rate of Pb is proportional to the Pb-bearing surface area. As particle size decreases, there is a corresponding increase in surface area per unit weight of material.
Medlin (14) (21) . After mixing, a subsample was screened for priority pollutants by the U.S. EPA Region II's Edison, New Jersey, laboratory (22) . Lead and arsenic were the only contaminants found above trace or nondetectable levels. At 34 ppm, the calculated dose of arsenic to be administered in this study (approximately 3 pg) would be well below the 340 pg typically found in 8 oz of lobster meat (23) . In contrast, the concentration of Pb in the gross soil sample was 2240 ppm.
Soil drying was accomplished by air drying in a filtered incubator at room temperature for 8 days. The soil contained (Table 2) .
Duplicate samples of the sterilized material were characterized for Pb speciation and particle size distribution. A 10-g aliquot of the soil was divided in two and particle mineralogy was identified using an electron microprobe, according to the method of Davis et al. (24) .
Particle size distribution was determined using an electrozone sensor in an Elzone 280 PC System (Particle Data Laboratories, Elmhurst, IL). The particle size distribution indicated that 79.5% of the particles were < 20 pm (Figure 2) . The Pb speciation profile was dissimilar between the split samples. Because the variability in the speciation profile was inconsistent with the homogeneity demonstrated via Pb concentration, isotopic ratio, and particle size distribution, a repeat Pb speciation profile was performed. The repeat analysis resulted in a more homogenous profile, suggesting a possible "nugget effect" in one of the original duplicate samples. A nugget effect occurs when a partide with a heavily concentrated predominant Pb form skews the species profile. In any case, mean values from the four speciation profiles are presented in Figure 3 .
Clinical and Laboratory Methods
The soil ingestion study was (Table 3 ). In the nonfasted group (group 2), the mean subject weight was 67.9 kg, resulting in an average soil dose of 82.9 mg.
On day 2, the subjects in group 1 received no breakfast, a standardized liquid lunch at noon, and a standardized dinner at 5:00 P.M. They received a standardized breakfast and lunch on day 3. The protocol was identical for group 2, except that this group received a standardized high-fat breakfast at 6:45 A.M. on day 2 immediately prior to the soil Pb administration. Breakfast consisted of 25 g of wheat cereal, 130 g of whole milk, 1 large hard-boiled egg (approximately 48 g), 50 g of firm whole wheat bread, 6 g of butter, 5 g of jam/preservatives, and 6 g of white sugar. The total calories consumed with this meal was 430, with 15% coming from protein, 51% from carbohydrates, and 33% from fat. The breakfast contained 255 mg of calcium and 418 mg of phosphorus. All meals were prepared in duplicate and analyzed for Pb content, which was unremarkable at < 0.5 ppm Pb dry weight.
The ratio of 206Pb/207Pb and total Pb content were simultaneously measured in the blood. An appropriate quantity of 205Pb was added as an internal standard to each blood sample, which was then decomposed by boiling in concentrated HNO3. The solution was evaporated to dryness and the residue charred at 250°C. Pb 
Results
The demographic characteristics of the study subjects are presented in Table 3 . Prior to ingestion of the soil, the mean PbB in the fasted group was 1.59 pg/dl and the mean 206Pb/207Pb ratio was 1.195. Thirty hours after soil administration, the PbB rose to a mean value of 2.6 pg/dl (p= 0.02) and the 206Pb/207Pb ratio fell to a mean value of 1.166 (p = 0.0001). In contrast, the PbB in the fed group rose by only 0.3 pg/dl, whereas the 206Pb/207Pb ratio fell by only 0.004 These changes were essentially complete by 24 hr. Typical absorption profiles from subjects in the fed and fasted groups are presented in Figure 4A and B, respectively. The absorption profile presented in Figure 4 , for example, demonstrates the remarkable sensitivity of the stable isotope dilution technique. This subject had both the lowest baseline PbB (0.7 pg/dl) and the smallest increase in PbB among fasted subjects (0.5 pg/dl) following ingestion of the soil, yet soil and nonsoil Pb sources could readily be distinguished.
On average, at 24 hr, we could account for 14.4% ± 4.5 of the administered Pb dose in the blood compartment of the fasted subjects. Bioavailability is traditionally estimated by comparing the kinetics of an oral dose to those of an intravenous dose. Previous studies of intravenous 203Pb (26) (27) (28) indicate that at 24 hr, 55% of an administered dose is still in the blood compartment. In this manner, we estimated the mean fraction of Pb absorbed from the soil sample to be 26.2% ± 8.1, with a range of 18.0 to 36.6%. In the six fed subjects, 1.4% ± 0.9 of the administered Pb dose was present in the blood compartment at 24 hr. Consequently, the estimated mean fraction of Pb absorbed in this group is 2.52% ± 1.7 (range 0.2-5.2%).
Discussion
The hazard posed by Pb-contaminated soils has and continues to be of great interest to organizations, such as the U.S. EPA, with public health and regulatory mandates. The intent of this research project is to provide experimental data that will better enable the U.S. EPA and similar agencies to assess and regulate the widespread soilborne Pb contamination in nonresidential areas throughout the United States. Biokinetic models that assess the impact of Pb-contaminated soil have had to estimate the bioavailability of soilborne Pb by extrapolating from dietary exposure studies in humans and/or soil-feeding studies in animals. The strength of the current study is that it directly examines human Pb bioavailability in a contaminated soil sample obtained from a hazardous waste site. In addition, the soil sample contains a Pb concentration (2924 ppm) that is commonly encountered at sites undergoing remedial investigation, and the amount of soil administered (72.9 and 82.9 mg) approximates the range estimated [20-80 mg (29) ] for normal daily soil ingestion by adults.
Although the study design strived to mimic an actual exposure scenario, it is unlikely that the daily soil ingested by an adult occurs as a bolus. Estimates of incidental daily soil ingestion in adults, though poorly defined, are associated with mouthing activities. The repetitive nature of these activities (e.g., smoking, eating, etc.) leads to soil ingestion throughout the day. Ideally, experimental soil administration should occur in a pattern that simulates reallife exposure; however, practical considerations make this an extraordinarily difficult task. Therefore, as a concession to practicality, we administered the soil as a bolus and recognized the possible limitations of this dosing regimen. However, the comparatively small tracer dose of Pb administered, even as a bolus, seems unlikely to result in saturable kinetics (8, 30) .
The lack of speciation homogeneity between duplicate soil samples raised a concern regarding the results of the soil bioavailability study. Possible differences in the Pb speciation profile across the administered soil samples introduces the possibility that the variance in absorption fraction within each of the test groups could have included variance due to Pb speciation rather than simply variance due to interindividual variability. Also, a lack of homogeneity in soil Pb speciation reduces the confidence in projecting the results of the soil bioavailability study as being representative of a particular profile of physicochemical soil/Pb characteristics. Nevertheless, this type of microheterogeneity in speciation likely occurs at many sites around the world.
Various investigators (9) (10) (11) have demonstrated absorption in the range of 30 to 70% when solubilized Pb was administered to fasted subjects. These same investigators (9-11) demonstrated significantly reduced absorption (range 3.5-9%) when solubilized Pb was administered with a meal. The results of our soil bioavailability study are consistent with that trend, in that absorption was approximately an order of magnitude different (2.5% vs 26.1%) between the fasted and fed states, respectively.
In conclusion, we believe that this experimental model provides important new information that supplements that obtained from observational epidemiologic studies of soil Pb/PbB relationships. The generalizability of these findings to other soils or to remediated sites is not known but can be determined experimentally using this in vivo model.
